Skip to content

Filana Therapeutics, Inc.

FLNA· NasdaqCore metricsCIK 1069530

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -8.83%
Market cap
$22.10M
50.27M shares
Filings
1,013
$35.24M
Q4 2013+277.6% FY13 yoy
-$10.73M
Q3 2026N/M FY25 yoy
-$11.27M
Q3 2026N/M FY25 yoy
-$18.88M
Q3 2026derivedN/M FY25 yoy
-$1.88
FY 2025N/M FY25 yoy
$46.99M
Q3 2026−25.7% FY25 yoy
$22.10M
—
—
0.4×
-148.58%
—

FY2025 figures · derived

Price

$0.439685.82%$2.6604past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$26.59MFY 2025
$89.42M0FY 2012FY 2017FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$26,590,000reported
FY 20242024-12-31$69,637,000reported
FY 20232023-12-31$89,423,000reported
FY 20222022-12-31$68,032,000reported
FY 20212021-12-31$24,813,000reported
FY 20182018-12-31$2,969,000reported
FY 20172017-12-31$7,615,000reported
FY 20162016-12-31$9,176,000reported
FY 20152015-12-31$9,100,000reported
FY 20142014-12-31$7,306,000reported
FY 20132013-12-31$4,917,000reported
FY 20122012-12-31$7,605,000reported

Pharmaceutical preparations

Filana Therapeutics, Inc. is the 376th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR